Evidence map›Paper›PMID 36944678›Full record

ArticleScientific reports2023

Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach.

Kyung Don Yoo, Junhyug Noh, Wonho Bae, Jung Nam An, Hyung Jung Oh, Harin Rhee, Eun Young Seong, Seon Ha Baek, Shin Young Ahn, Jang-Hee Cho and 6 more

Open access · goldFull text readMulticenter Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 17 institutions in 5 countries.

Kyung Don YooDivision of Nephrology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Junhyug NohLawrence Livermore National Laboratory, Livermore, CA, USA.
Wonho BaeUniversity of British Columbia, Vancouver, Canada.
Jung Nam AnDivision of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Hyung Jung OhDivision of Nephrology, Department of Internal Medicine, Sheikh Khalifa Specialty Hospital, Ra's al Khaimah, United Arab Emirates.
Harin RheeDivision of Nephrology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Eun Young SeongDivision of Nephrology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Seon Ha BaekDivision of Nephrology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea.
Shin Young AhnDivision of Nephrology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Jang-Hee ChoDivision of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.
Dong Ki KimDivision of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Dong-Ryeol RyuDivision of Nephrology, Department of Internal Medicine, School of Medicine, Ehwa Womans University, Seoul, Republic of Korea.
Sejoong KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Chun Soo LimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Jung Pyo LeeDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. nephrolee@gmail.com.
Korean Association for the Study of Renal Anemia and Artificial Intelligence (KARAI)
Seoul National University · KRPusan National University Hospital · KRCatholic University of Korea · KREwha Womans University · KRHallym University Dongtan Sacred Heart Hospital · KRHallym University Sacred Heart Hospital · KRKorea University · KRKorea University Medical Center · KRKyungpook National University Hospital · KRLawrence Livermore National Laboratory · USNational Health Insurance Service · KRPusan National University · KRShaikh Khalifa Medical City · AESNUH SMG-SNU Boramae Medical Center · KRUlsan University Hospital · KRUniversity of British Columbia · CAYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluid balance is a critical prognostic factor for patients with severe acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). This study evaluated whether repeated fluid balance monitoring could improve prognosis in this clinical population. This was a multicenter retrospective study that included 784 patients (mean age, 67.8 years; males, 66.4%) with severe AKI requiring CRRT during 2017-2019 who were treated in eight tertiary hospitals in Korea. Sequential changes in total body water were compared between patients who died (event group) and those who survived (control group) using mixed-effects linear regression analyses. The performance of various machine learning methods, including recurrent neural networks, was compared to that of existing prognostic clinical scores. After adjusting for confounding factors, a marginal benefit of fluid balance was identified for the control group compared to that for the event group (p = 0.074). The deep-learning model using a recurrent neural network with an autoencoder and including fluid balance monitoring provided the best differentiation between the groups (area under the curve, 0.793) compared to 0.604 and 0.606 for SOFA and APACHE II scores, respectively. Our prognostic, deep-learning model underlines the importance of fluid balance monitoring for prognosis assessment among patients receiving CRRT.

Indexed as

Acute Kidney InjuryContinuous Renal Replacement TherapyDeep LearningAgedBody CompositionHumansMalePrognosisRetrospective Studies

Identifiers

PMID36944678
PMCPMC10030803
OpenAlexW4328126401

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.